Packers Rule Out CB Kevin King Against Redskins With Shoulder Injury
By Jerry Trotta

The Green Bay Packers are heavily favored to come out of Week 14 with a win at Lambeau Field against the 3-9 Washington Redskins. Therefore, they are taking no risks with the health of certain players.
Starting cornerback Kevin King, who was listed as questionable after getting in a full practice on Friday, has been ruled OUT for Sunday's game with a shoulder impingement.
An interesting name on inactive list: #Packers CB Kevin King won't be available v Washington. He was a full participant in Friday's practice but listed as "questionable" on injury report because of his shoulder, which has given him problems before. No need to risk anything today.
— Ryan Wood (@ByRyanWood) December 8, 2019
The University of Washington product missing out could probably be used as an opportunity to get his mind right as he has largely struggled throughout 2019.
In King's absence, Packers fans can expect Jaire Alexander and Tramon Williams to get the start at CB. Behind them, Chandon Sullivan, Josh Jackson and even safety Will Redmond could get some run in the rotation on Sunday.
So with Kevin King out, #Packers clearly not wanting to risk anything with his shoulder, GB will be short in the secondary today. We'll see how they line up, but wouldn't be surprise if Tramon Williams moved outside to perimeter, and Chandon Sullivan replaced him in the slot.
— Ryan Wood (@ByRyanWood) December 8, 2019
On top of King, however, Green Bay also ruled out CBs Tony Brown and Ka’dar Hollman, so they will be alarmingly short at the position against Dwayne Haskins and the Redskins.
Here are #Packers full inactives vs. Washington:
— Ryan Wood (@ByRyanWood) December 8, 2019
WR Ryan Grant
CB Kevin King
RB Dexter Williams
CB Tony Brown
CB Ka'dar Hollman
G/T Adam Pankey
T Yosh Nijmans
Still, we expect that Alexander, Williams, and Co. should be enough to handle a Washington offense that currently ranks dead last in the NFL in terms of yards per game with a lowly 262.4 mark.